301 related articles for article (PubMed ID: 38649653)
21. The Etiology and Impact of Muscle Wasting in Metastatic Cancer.
Biswas AK; Acharyya S
Cold Spring Harb Perspect Med; 2020 Oct; 10(10):. PubMed ID: 31615873
[TBL] [Abstract][Full Text] [Related]
22. RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice.
Pin F; Jones AJ; Huot JR; Narasimhan A; Zimmers TA; Bonewald LF; Bonetto A
J Bone Miner Res; 2022 Mar; 37(3):381-396. PubMed ID: 34904285
[TBL] [Abstract][Full Text] [Related]
23. Skeletal muscle omics signatures in cancer cachexia: perspectives and opportunities.
Gilmore LA; Parry TL; Thomas GA; Khamoui AV
J Natl Cancer Inst Monogr; 2023 May; 2023(61):30-42. PubMed ID: 37139970
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexia.
Weber BZC; Agca S; Domaniku A; Bilgic SN; Arabaci DH; Kir S
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1582-1594. PubMed ID: 35373517
[TBL] [Abstract][Full Text] [Related]
25. Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics.
Balsano R; Kruize Z; Lunardi M; Comandatore A; Barone M; Cavazzoni A; Re Cecconi AD; Morelli L; Wilmink H; Tiseo M; Garajovà I; van Zuylen L; Giovannetti E; Piccirillo R
Cells; 2022 Aug; 11(17):. PubMed ID: 36078078
[TBL] [Abstract][Full Text] [Related]
26. Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?
Mueller TC; Bachmann J; Prokopchuk O; Friess H; Martignoni ME
BMC Cancer; 2016 Feb; 16():75. PubMed ID: 26856534
[TBL] [Abstract][Full Text] [Related]
27. Bone morphogenetic protein signaling in musculoskeletal cancer.
Bami M; Mavrogenis AF; Angelini A; Milonaki M; Mitsiokapa E; Stamoulis D; Soucacos PN
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2061-72. PubMed ID: 27043154
[TBL] [Abstract][Full Text] [Related]
28. Endoplasmic Reticulum Stress, Calcium Dysregulation and Altered Protein Translation: Intersection of Processes That Contribute to Cancer Cachexia Induced Skeletal Muscle Wasting.
Isaac ST; Tan TC; Polly P
Curr Drug Targets; 2016; 17(10):1140-6. PubMed ID: 25882219
[TBL] [Abstract][Full Text] [Related]
29. Exosomal lncRNA HOTAIR promotes osteoclast differentiation by targeting TGF-β/PTHrP/RANKL pathway.
Zhang C; Yang J; Zhu Z; Qin J; Yang L; Zhao X; Su W; Cai Y; Yang J; Wang F; Chen W; Gu H; Deng H; Wang Z
Basic Clin Pharmacol Toxicol; 2023 Mar; 132(3):242-252. PubMed ID: 36482064
[TBL] [Abstract][Full Text] [Related]
30. Loss of strength capacity is associated with mortality, but resistance exercise training promotes only modest effects during cachexia progression.
das Neves W; Alves CR; de Almeida NR; Guimarães FL; Ramires PR; Brum PC; Lancha AH
Life Sci; 2016 Oct; 163():11-22. PubMed ID: 27575705
[TBL] [Abstract][Full Text] [Related]
31. Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?
Dolly A; Dumas JF; Servais S
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1413-1428. PubMed ID: 33053604
[TBL] [Abstract][Full Text] [Related]
32. Loss of skeletal muscle in cancer: biochemical mechanisms.
Tisdale MJ
Front Biosci; 2001 Feb; 6():D164-74. PubMed ID: 11171557
[TBL] [Abstract][Full Text] [Related]
33. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.
Lima JDCC; Simoes E; de Castro G; Morais MRPT; de Matos-Neto EM; Alves MJ; Pinto NI; Figueredo RG; Zorn TMT; Felipe-Silva AS; Tokeshi F; Otoch JP; Alcantara P; Cabral FJ; Ferro ES; Laviano A; Seelaender M
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1045-1059. PubMed ID: 31273954
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs as potential therapeutic targets for muscle wasting during cancer cachexia.
Sannicandro AJ; McDonagh B; Goljanek-Whysall K
Curr Opin Clin Nutr Metab Care; 2020 May; 23(3):157-163. PubMed ID: 32073414
[TBL] [Abstract][Full Text] [Related]
35. MC38 Tumors Induce Musculoskeletal Defects in Colorectal Cancer.
Huot JR; Pin F; Essex AL; Bonetto A
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540821
[TBL] [Abstract][Full Text] [Related]
36. Assessing Metabolic Dysregulation in Muscle During Cachexia.
Hsu MY; Porporato PE; Wyart E
Methods Mol Biol; 2019; 1928():337-352. PubMed ID: 30725463
[TBL] [Abstract][Full Text] [Related]
37. Understanding and targeting osteoclastic activity in prostate cancer bone metastases.
Sottnik JL; Keller ET
Curr Mol Med; 2013 May; 13(4):626-39. PubMed ID: 23061677
[TBL] [Abstract][Full Text] [Related]
38. STAT3 in the systemic inflammation of cancer cachexia.
Zimmers TA; Fishel ML; Bonetto A
Semin Cell Dev Biol; 2016 Jun; 54():28-41. PubMed ID: 26860754
[TBL] [Abstract][Full Text] [Related]
39. Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia.
Sartori R; Hagg A; Zampieri S; Armani A; Winbanks CE; Viana LR; Haidar M; Watt KI; Qian H; Pezzini C; Zanganeh P; Turner BJ; Larsson A; Zanchettin G; Pierobon ES; Moletta L; Valmasoni M; Ponzoni A; Attar S; Da Dalt G; Sperti C; Kustermann M; Thomson RE; Larsson L; Loveland KL; Costelli P; Megighian A; Merigliano S; Penna F; Gregorevic P; Sandri M
Sci Transl Med; 2021 Aug; 13(605):. PubMed ID: 34349036
[TBL] [Abstract][Full Text] [Related]
40. Role of interleukin-6 in cachexia: therapeutic implications.
Narsale AA; Carson JA
Curr Opin Support Palliat Care; 2014 Dec; 8(4):321-7. PubMed ID: 25319274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
